Biomerica Inc SEC filings BMRA
Biomerica Inc has 605 filings in SEC EDGAR's recent list, going back to Sep 28, 1995. Its latest annual report, Form 10-K, was filed on Aug 31, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 15, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K/A | Amended annual report | Sep 28, 2026 | May 31, 2026 |
| 10-K | Annual report | Aug 31, 2026 | May 31, 2026 |
| 10-K/A | Amended annual report | Sep 26, 2025 | May 31, 2025 |
| 10-K | Annual report | Aug 29, 2025 | May 31, 2025 |
| 10-K | Annual report | Aug 28, 2024 | May 31, 2024 |
| 10-K | Annual report | Aug 25, 2023 | May 31, 2023 |
| 10-K | Annual report | Aug 29, 2022 | May 31, 2022 |
| 10-K/A | Amended annual report | Oct 14, 2021 | May 31, 2021 |
| 10-K | Annual report | Aug 27, 2021 | May 31, 2021 |
| 10-K | Annual report | Aug 31, 2020 | May 31, 2020 |
| 10-K | Annual report | Aug 29, 2019 | May 31, 2019 |
| 10-K | Annual report | Aug 29, 2018 | May 31, 2018 |
| 10-K | Annual report | Aug 29, 2017 | May 31, 2017 |
| 10-K | Annual report | Aug 29, 2016 | May 31, 2016 |
| 10-K | Annual report | Aug 31, 2015 | May 31, 2015 |
| 10-K | Annual report | Aug 29, 2014 | May 31, 2014 |
| 10-K | Annual report | Aug 29, 2013 | May 31, 2013 |
| 10-K | Annual report | Aug 29, 2012 | May 31, 2012 |
| 10-K | Annual report | Aug 30, 2011 | Jul 29, 2011 |
| 10-K | Annual report | Aug 30, 2010 | May 31, 2010 |
| 10-K | Annual report | Aug 31, 2009 | May 31, 2009 |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- BMRA (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 73290
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.